Does triheptanoin improve brain energy metabolism in patients with Huntington disease?
This study suggests that triheptanoin is able to correct the bioenergetic profile in the brain of patients with HD at an early stage of the disease.
Our study indicates that CA12 may be used as a novel prognostic marker in combination with histologic grade of the tumors.